I

Instituto de Neumonologia y Dermatologia | Buenos Aires, Argentina

Research site

(Unclaimed)

Location

Arenales 2557 1A, Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina

Site insights

Top conditions

Top treatments

JNJ-77242113

Deucravacitinib

JNJ-95475939

Ustekinumab

Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) (DUPLEX-AD)

The purpose of this study is to evaluate how well JNJ-95475939 works as compared to placebo in participants with moderate to severe atopic dermatitis.

Enrolling

Dermatitis, Atopic

Drug: Placebo

Drug: JNJ-95475939

A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ASCEND)

The main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to sev...

Enrolling

Plaque Psoriasis

Drug: Ustekinumab

Drug: Matching Placebo to Ustekinumab